Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kathy Bang"'
Autor:
Luis Alejandro Zúñiga, Torben Leßmann, Karan Uppal, Nicola Bisek, Enping Hong, Caroline E. Rasmussen, Jens-Jakob Karlsson, Joachim Zettler, Lars Holten-Andersen, Kathy Bang, Dhruv Thakar, Yu-Chi Lee, Salomon Martinez, Simran Singh Sabharwal, Sebastian Stark, Frank Faltinger, Oliver Kracker, Samuel Weisbrod, Robin Müller, Tobias Voigt, Kornelia Bigott, Mohammad Tabrizifard, Vibeke Miller Breinholt, Amer M. Mirza, David B. Rosen, Kennett Sprogøe, Juha Punnonen
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background Intratumoral (IT) delivery of toll-like receptor (TLR) agonists has shown encouraging anti-tumor benefit in preclinical and early clinical studies. However, IT delivery of TLR agonists may lead to rapid effusion from the tumor mic
Externí odkaz:
https://doaj.org/article/9c07ff8778c14891ac4c75977cba6fba
Autor:
Anne Månsson Kvarnhammar, Juha Punnonen, Enping Hong, Diana Reich, Karan Uppal, Kathy Bang, David B Rosen, Burkhardt Laufer, Thomas Knappe, Jens Jakob Karlsson, Yu-Chi Lee, Dhruv Thakar, Luis Alejandro Zúñiga, Simran Singh Sabharwal, Janne Damm Olling, Kristian Kjaergaard, Thomas Kurpiers, Meike Schnabel, Philipp Glock, Joachim Zettler, Mathias Krusch, Ana Bernhard, Stefan Heinig, Valentino Konjik, Thomas Wegge, Yvonne Hehn, Steffen Killian, Laura Viet, Josefine Runz, Frank Faltinger, Mohammad Tabrizi, Kristin Laura Abel, Vibeke Miller Breinholt, Stina M Singel, Kennett Sprogøe
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Background Recombinant interleukin-2 (IL-2, aldesleukin) is an approved cancer immunotherapy but causes severe toxicities including cytokine storm and vascular leak syndrome (VLS). IL-2 promotes antitumor function of IL-2Rβ/γ+ natural killer (NK) c
Externí odkaz:
https://doaj.org/article/c5975468cd0f4febb405f737118e732f
Autor:
Amer Mirza, David Rosen, Juha Punnonen, Enping Hong, Luis Zuniga, Karan Uppal, Kathy Bang, Simran Sabharwal, Yuchi Lee, Salomon Martinez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ab51cf4acb4a48fda431edd435e3dc09
Autor:
Amer Mirza, David Rosen, Juha Punnonen, Enping Hong, Luis Zuniga, Karan Uppal, Kathy Bang, Simran Sabharwal, Yuchi Lee, Solomon Martinez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/2213c1af161a460dae21110d56f96d23
Autor:
Luis A. Zúñiga, Daniel J. Cua, Christopher Stevenson, Kathy Bang, Michele Bauer, Marie Semana, Roanna Ueda, Barbara Joyce-Shaikh, Dana Tedesco, Jeff Grein, David B. Rosen, Simran S. Sabharwal
GITR is a costimulatory receptor currently undergoing phase I clinical trials. Efficacy of anti-GITR therapy in syngeneic mouse models requires regulatory T-cell depletion and CD8+ T-cell costimulation. It is increasingly appreciated that immune cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ada4067761ee926ccdf445f6e5e0949
https://doi.org/10.1158/2326-6066.c.6548267.v1
https://doi.org/10.1158/2326-6066.c.6548267.v1
Autor:
Luis A. Zúñiga, Daniel J. Cua, Christopher Stevenson, Kathy Bang, Michele Bauer, Marie Semana, Roanna Ueda, Barbara Joyce-Shaikh, Dana Tedesco, Jeff Grein, David B. Rosen, Simran S. Sabharwal
PhosFlow and Ki67 data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f12c458b1e1bd437e33df412012326
https://doi.org/10.1158/2326-6066.22536902
https://doi.org/10.1158/2326-6066.22536902
Autor:
Luis A. Zúñiga, Daniel J. Cua, Christopher Stevenson, Kathy Bang, Michele Bauer, Marie Semana, Roanna Ueda, Barbara Joyce-Shaikh, Dana Tedesco, Jeff Grein, David B. Rosen, Simran S. Sabharwal
Legends for the 3 Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20f0f27bac66d6ee0c6fe2afd8132daa
https://doi.org/10.1158/2326-6066.22536899.v1
https://doi.org/10.1158/2326-6066.22536899.v1
Autor:
Dana Tedesco, Simran S. Sabharwal, Roanna Ueda, Marie Semana, Michele Bauer, Daniel J. Cua, Barbara Joyce-Shaikh, Christopher Stevenson, Rosen David B, Luis A. Zuniga, Kathy Bang, Jeff Grein
Publikováno v:
Cancer Immunology Research. 6:1199-1211
GITR is a costimulatory receptor currently undergoing phase I clinical trials. Efficacy of anti-GITR therapy in syngeneic mouse models requires regulatory T-cell depletion and CD8+ T-cell costimulation. It is increasingly appreciated that immune cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02ea82eb52f172d5609cb063751b0305
https://doi.org/10.1158/2326-6066.cir-17-0632
https://doi.org/10.1158/2326-6066.cir-17-0632
Autor:
Juha Punnonen, Salomon Martinez, Luis A. Zuniga, Simran S. Sabharwal, Yuchi Lee, Rosen David B, Karan Uppal, Enping Hong, Kathy Bang, Amer Mirza
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundTLR agonists can elicit anti-tumor activity by activating innate immune cells and promoting a proinflammatory microenvironment. Local delivery of TLR agonists has shown encouraging preclinical and clinical anti-tumor activity. However, intr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9415bf3b853d017915bc9a7be77f6e9
https://doi.org/10.1136/jitc-2021-sitc2021.016
https://doi.org/10.1136/jitc-2021-sitc2021.016
Autor:
Simran S, Sabharwal, David B, Rosen, Jeff, Grein, Dana, Tedesco, Barbara, Joyce-Shaikh, Roanna, Ueda, Marie, Semana, Michele, Bauer, Kathy, Bang, Christopher, Stevenson, Daniel J, Cua, Luis A, Zúñiga
Publikováno v:
Cancer immunology research. 6(10)
GITR is a costimulatory receptor currently undergoing phase I clinical trials. Efficacy of anti-GITR therapy in syngeneic mouse models requires regulatory T-cell depletion and CD8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::185ee8a3824c80d2cc28744b6f1da00b
https://pubmed.ncbi.nlm.nih.gov/30154083
https://pubmed.ncbi.nlm.nih.gov/30154083